Related references
Note: Only part of the references are listed.Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study
Linda Granowetter et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Results of the EICESS-92 study:: Two randomized trials of Ewing's sarcoma treatment -: Cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients
Michael Paulussen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Predictive factors of histologic response to primary chemotherapy in patients with Ewing sarcoma
Stefano Ferrari et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2007)
Impact of high-dose busulfan plus melphalan as consolidation in metastatic Ewing tumors: A study by the Societe Francaise des Cancers de l'Enfant
Odile Oberlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours
A. McTiernan et al.
ANNALS OF ONCOLOGY (2006)
Ewing's sarcoma family of tumors: Current management
Mark Bernstein et al.
ONCOLOGIST (2006)
Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992
G Bacci et al.
EUROPEAN JOURNAL OF CANCER (2004)
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone
HE Grier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)
O Oberlin et al.
BRITISH JOURNAL OF CANCER (2001)
Five-year results in Ewing's sarcoma.: The Scandinavian Sarcoma Group experience with the SSG IX protocol
I Elomaa et al.
EUROPEAN JOURNAL OF CANCER (2000)
Share Paper
